BamSEC and AlphaSense Join Forces
Learn More

Lantheus Holdings Inc. – Material Contracts

NASDAQ: LNTH    
Share price (10/14/26): $100.00    
Market cap (10/14/26): $6.527 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 10-Q 6 pages Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.4
from 10-Q 9 pages Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan Stock Option Award Agreement
12/34/56
EX-10.3
from 10-Q 11 pages Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.2
from 10-Q 7 pages Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.2
from 8-K 3 pages Amendment to Severance Letter Agreement
12/34/56
EX-10.1
from 8-K 3 pages [Date] via Electronic Mail [Name] [Address] Re: Transaction Bonus as You Know, Lantheus Holdings, Inc. (“Lantheus”) Is Entering Into an Agreement and Plan of Merger With Curium US Holdings LLC and the Other Parties Thereto (The “Merger Agreement” and the Transactions Contemplated by the Merger Agreement, the “Merger”)
12/34/56
EX-10.4
from 10-Q 8 pages 2 June 2025 L Dinkelborg Life Molecular Imaging Gmbh Dear Ludger
12/34/56
EX-10.3
from 10-Q 10 pages Certain Identified Information Has Been Omitted From This Exhibit Because It Is (I) Not Material and (II) of the Type That the Registrant Treats as Private or Confidential. [***] Indicates the Information Has Been Omitted. Dr Ludger Dinkelborg
12/34/56
EX-10.2
from 10-Q 8 pages July 30, 2025 via Electronic Mail Dr. Ludger Dinkelborg Re: Severance
12/34/56
EX-10.1
from 10-Q 11 pages Service Agreement
12/34/56
EX-10.1
from 8-K 22 pages Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan
12/34/56
EX-10.36
from 10-K 4 pages November 7, 2025 via Email Mary Anne Heino 40 McCaskill Road West Pinehurst, Nc 28374 Dear Mary Anne: At the Direction of the Board of Directors (The “Board”) of Lantheus Holdings, Inc. (“Lantheus” or the “Company”), I Am Pleased to Extend This Offer to You. This Offer Reflects the Terms and Conditions Recommended by the Talent and Compensation Committee (“Tcc”) and Approved by the Board. It Also Includes Important Details About Your Onboarding, Compensation, Benefits, and the Terms and Conditions of Your Employment With Lantheus
12/34/56
EX-10.35
from 10-K 5 pages Retirement and Separation Agreement
12/34/56
EX-10.34
from 10-K 9 pages Consulting Agreement
12/34/56
EX-10.1
from 10-Q 172 pages July 2025 Deed of Amendment and Restatement Relating to a Sale and Purchase Agreement Entered Into by the Following Parties: Life Medical Group Limited and Life Healthcare Group Holdings Limited and Lantheus Radiopharmaceuticals Uk Limited and Lantheus Medical Imaging, Inc
12/34/56
EX-10.1
from 10-Q 2 pages Ninth Amendment to Lantheus Holdings, Inc. 2015 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 7 pages Third Amendment to Lease
12/34/56
EX-10.37
from 10-K 152 pages Pursuant to Item 601(b)(10) of Regulation S-K, Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced by [***], as the Identified Confidential Portions (I) Are Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.36
from 10-K 42 pages Section 1. Purpose
12/34/56
EX-10.35
from 10-K 19 pages Indemnification Agreement
12/34/56